Second edition

08.qxd 3/10/08 9:38 AM Page 391
Leckman JF, Zhang H, Vitale A et al. Course of tic severity in
Tourette syndrome: the first two decades. Pediatrics 1998;
102:14–19.
Lee MS, Lee SB, Kim WC. Spasmodic dysphonia associated with a
left ventrolateral putaminal lesion. Neurology 1996;
47:827–8.
Lee MS, Kim YD, Lyoo CH. Oculogyric crisis as an initial
manifestation of Wilson’s disease. Neurology 1999;
52:1714–15.
Lees AJ, Robertson M, Trimble MR et al. A clinical study of Gilles
de la Tourette syndrome in the United Kingdom. J Neurol
Neurosurg Psychiatry 1984; 47:1–9.
Lennox G, Lowe J, Landon M et al. Diffuse Lewy body disease:
correlative neuropathology using anti-ubiquitin
immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;
52:1236–47.
Leopold NA, Kagel MC. Dysphagia in Huntington’s disease. Arch
Neurol 1985; 42:57–60.
Lesse SM. Huntington’s chorea: report of a case. J Nerv Ment Dis
1946; 104:84–7.
Leube B, Hendgen J, Kessler KR et al. Sporadic focal dystonia in
Northwest Germany: molecular basis on chromosome 18p.
Ann Neurol 1997; 42:111–14.
Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the
chromosome 1 familial Alzheimer’s disease locus. Science
1995; 269:973–7.
Lieberman A, Ranhosky A, Korts D. Clinical evaluation of
pramipexole in advanced Parkinson’s disease: results of a
double-blind, placebo-controlled, parallel-group study.
Neurology 1997; 49:162–8.
Lieberman A, Olanow CW, Sethi K et al. A multicenter trial of
ropinirole as adjunct treatment for Parkinson’s disease.
Neurology 1998; 51:1057–62.
Lieberman JA, Reife R. Spastic dysphonia and denervation signs in
a young man with tardive dyskinesia. Br J Psychiatry 1989;
154:105–9.
Lilly R, Cummings JL, Benson DF et al. The human Kluver–Bucy
syndrome. Neurology 1983; 33:1141–5.
Linet LS. Tourette syndrome, pimozide, and school phobia: the
neuroleptic separation anxiety syndrome. Am J Psychiatry
1985; 12:613–15.
Linn RT, Wolf PA, Bachman DL et al. The ‘preclinical phase’ of
probable Alzheimer’s disease. Arch Neurol 1995; 52:485–90.
Lippa CF, Smith TW, Swearer JM. Alzheimer’s disease and Lewy
body disease: a comparative clinicopathological study. Ann
Neurol 1994; 35:81–8.
Little BW, Brown PW, Rodgers-Johnson P et al. Familial myoclonic
dementia masquerading as Creutzfeldt–Jakob disease. Ann
Neurol 1986; 20:231.
Litvan I, Mega MS, Cummings JL et al. Neuropsychiatric aspects
of progressive supranuclear palsy. Neurology 1996a; 47:
1184–9.
Litvan I, Mangone CA, McKee A et al. Natural history of
progressive supranuclear palsy (Steele–Richardson–
Olszewski syndrome) and clinical predictors of survival: a
clinicopathologic study. J Neurol Neurosurg Psychiatry 1996b;
61:615–20.
References 391
Litvan I, Agid Y, Jankovic J et al. Accuracy of clinical criteria for
the diagnosis of progressive supranuclear palsy
(Steele–Richardson Olszewski syndrome). Neurology 1996c;
46:922–30.
Litvan I, Agid Y, Sastrj N et al. What are the obstacles for
accurate clinical diagnosis of Pick’s disease? Neurology
1997a; 49:62–9.
Litvan I, Campbell G, Mangone CA et al. Which clinical features
differentiate progressive supranuclear palsy
(Steele–Richardson–Olszewski syndrome) from related
disorders? A clinicopathological study. Brain 1997b;
120:65–74.
Litvan I, Agid Y, Goetz C et al. Accuracy of the clinical diagnosis
of corticobasal degeneration: a clinicopathologic study.
Neurology 1997c; 48:119–25.
Litvan I, Cummings JL, Mega M. Neuropsychiatric features of
corticobasal degeneration. J Neurol Neurosurg Psychiatry
1998; 65:717–21.
Litvan I, Phipps M, Pharr VL et al. Randomized placebo-controlled
trial of donepezil in patients with progressive supranuclear
palsy. Neurology 2001; 57:467–73.
Livingston G, Walker AE, Katona CLE et al. Antipsychotics and
cognitive decline in Alzheimer’s disease: the LASER-
Alzheimer’s disease longitudinal study. J Neurol Neurosurg
Psychiatry 2007; 78:25–9.
Lopes-Cendes I, Silveira I, Maciel P et al. Limits of clinical
assessment as the accurate diagnosis of Machado–Joseph
disease. Arch Neurol 1996; 53:1168–74.
Lopez OL, Becker JT, Sweet RA et al. Psychiatric symptoms vary
with the severity of dementia in probable Alzheimer’s disease.
J Neuropsychiatry Clin Neurosci 2003; 15:346–53.
Lorenz D, Frederiksen H, Moises H et al. High concordance for
essential tremor in monozygotic twins of old age. Neurology
2004; 62:208–11.
Lossos A, Dobson-Stone C, Monaco AP et al. Early clinical
heterogeneity in choreoacanthocytosis. Ann Neurol 2005;
62:611–14.
Lou J-S, Jankovic J. Essential tremor: clinical correlates in 350
patients. Neurology 1991; 41:234–8.
Louis ED, Goldman JE, Powers JM et al. Parkinsonian features of
eight pathologically diagnosed cases of diffuse Lewy body
disease. Mov Disord 1995; 10:188–94.
Louis ED, Klatka LA, Liu Y et al. Comparison of extrapyramidal
features in 31 pathologically confirmed cases of diffuse Lewy
body disease and 34 pathologically confirmed cases of
Parkinson’s disease. Neurology 1997; 48:376–80.
Louis ED, Honig LS, Vonsattel JPG et al. Essential tremor
associated with focal nonnigral Lewy bodies. Arch Neurol
2005; 62:1004–7.
Louis ED, Vonsattel JPG, Honig LS et al. Neuropathologic findings
in essential tremor. Neurology 2006a; 66:1756–9.
Louis ED, Vonsattel JPG, Honig LS et al. Essential tremor
associated with pathologic change in the cerebellum. Arch
Neurol 2006b; 63:1189–93.
Lowenberg K, Boyd DA, Salon DD. Occurrence of Pick’s
disease in early adult years. Arch Neurol Psychiatry 1939;
41:1004–20.